• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for clinical trial

clinical trial

The life-changing impact of clinical trials

December 31, 2019

“OMRF has saved my life,” says MS patient Tonja Martin.

Filed Under: News Tagged With: clinical trial, Gabriel Pardo, MS, ms center, multiple sclerosis, Multiple Sclerosis Center of Excellence, Pardo, Tonjy Jartin

Joint interest: Understanding different types of arthritis

July 10, 2018

Arthritis is the leading cause of disability in the U.S., but it isn’t just one disease.

Filed Under: News Tagged With: arthritis, autoimmune, back, cartilage, cause, Chakravarty, clinical trial, conditions, cure, difficulty, disability, disease, distinct, Eliza, eliza chakravarty, fingers, hips, immune system, joint, knees, lab, newsok, oa, obesity, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, osteoarthritis, pain, ra, research, rheumatoid arthritis, risk, science, scientist-news, StopRA, trauma, treat, treatment

Berry benefit: Study shows strawberries might help combat osteoarthritis

December 4, 2017

Osteoarthritis is the most common form of disability in the U.S., but you might find an ally against it in the produce section.

Filed Under: News Tagged With: ally, anti-inflammatory, antioxidant, arthritis, biji kurien, biomarkers, cartilage, clinical trial, damage, disease, effects, fruit, Hal Scofield, inflammation, medications, newsok, oa, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, osteoarthritis, oxidant, research, robert, science, scientist-news, Scofield, strawberries, strawberry, study, trial

OMRF names new board member and VP

April 14, 2017

OMRF hosted its semiannual meeting on Thursday.

Filed Under: News Tagged With: 2017, army reserve, arthritis, biomedical, board, board of directors, chief judge, clinical affairs, clinical trial, conducts, david rainbolt, Deshmukh, federal trade commission, foundation, Holly, honorable, James, Judith, Judith James, m.d., meeting, member, MS, multiple sclerosis, newsok, nonprofit, OKC, Oklahoma, Oklahoma City, Oklahoma Medical Research Foundation, oklahoma state university, OMRF, osu hall of fame, ph.d., Pond Creek, ra, research, Sathish, school of law, scientist-news, semiannual, Srinivasan, terence kern, Tulsa, u.s. district court, Umesh, university of oklahoma, van remmen, vice president

Blood test identifies people at high risk for lupus

April 6, 2017

New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.

Filed Under: News Tagged With: anti-inflammatory, autoimmune, biomedical, chair, clinic, clinical trial, develop, disease, drug, guthridge, healthy, high risk, iowa, James, Joel, Judith, Judith James, lupus, m.d., Melissa Munroe, NIAID, NIH, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, ou, OUHSC, paper, partner, patients, ph.d., population, prevent, prevention, published, relative, scientist-news, smile, staff, study, symptoms, therapy, trial

Biotech company acquires OMRF brain cancer drug

February 15, 2016

Agreement will expand clinical trials of glioblastoma drug

Filed Under: News Tagged With: brain cancer, brain tumor, cancer, clinical trial, glioblastoma, glioma, Gtree, GtreeBNT, investigational drug, Manu Nair, Oblato, OKN-007, pharmaceuticals, Rheal, scientist-news, Towner

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In